Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study

Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study

"n Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 st1":*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; ms...

Full description

Bibliographic Details
Main Authors:	Modares Gilani M, Behtash N, Karimi Zarchi M, Samizadeh Z, Ghaemmaghami F, Mousavi A
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 2008-10-01
Series:	Tehran University Medical Journal
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/12103.pdf&manuscript_id=12103

Similar Items

Ovarian carcinoma associated with pregnancy: A clinicopathologic analysis of 23 cases and review of the literature
by: Ghaemmaghami Fatemeh, et al.
Published: (2008-01-01)

COMPARISON BETWEEN GEMCITABINE-CARBOPLATIN AND COMBINATION OF GEMCITABINE-CARBOPLATIN AND CELECOXIB IN UROTHELIAL CARCINOMA CELL APOPTOSIS
by: Widya Sakti Pratama, et al.
Published: (2019-01-01)

The effect of consolidation treatment with intraperitoneal carboplatin in advanced epithelial ovarian cancers
by: Azamsadat Mousavi, et al.
Published: (2014-07-01)

LONG TERM ORAL ETOPOSIDE AS SECOND LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY
by: A. S. Moosavi, et al.
Published: (2006-05-01)

LONG TERM ORAL ETOPOSIDE AS SECOND LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY
by: A. S. Moosavi, et al.
Published: (2006-02-01)

Cisplatin, cyclophosphamide versus taxol, carboplatin in epithelial ovarian carcinoma: a clinical trial
by: Modarres M, et al.
Published: (2007-05-01)

THE DIFFERENCES OF APOPTOSIS EFFECTS BETWEEN COMBINATION OF MELOXICAM WITH GEMCITABINE-CARBOPLATIN CHEMOTHERAPY COMPARED TO GEMCITABINE-CARBOPLATIN CHEMOTHERAPY ALONE IN UROTHELIAL CARCINOMA CULTURE CELLS
by: Ananta Cahyo Nugroho, et al.
Published: (2019-01-01)

Antitumor effects of combined carboplatin and gemcitabine in canine transitional cell carcinoma
by: De Brito Galvao, Joao Felipe
Published: (2011)

Gemcitabine in Combination with Carboplatin Exhibits Biologic Activity Against Canine Osteosarcoma
by: McMahon, Melanie B.
Published: (2009)

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer
by: Minami Seigo, et al.
Published: (2013-01-01)

Radical hysterectomy in the elderly
by: Shams Maryam, et al.
Published: (2008-04-01)

Fertility preservation in young women with endometrial carcinoma; report of three cases
by: Mousavi A.S, et al.
Published: (2007-06-01)

Pegylated Liposomal Doxorubicin as a Single Agent or as Combination Therapy with Carboplatin in Patients with Recurrent or Refractory Epithelial Ovarian Cancer
by: Keng SHEN, et al.
Published: (2009-12-01)

Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer
by: Joseph G Kattan, Celine Y Boutros, Fadi S Farhat, Georges Y Chahine, Khaled M Musallam, Marwan G Ghosn
Published: (2012-01-01)

Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer
by: Charles A Kunos, et al.
Published: (2015-06-01)

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy
by: Valerie A. Allen, et al.
Published: (2016-01-01)

Combination of gemcitabine and carboplatin in urothelial cancer patients unfit for cisplatin due to impaired renal or cardiac function
by: Avishay Sella, et al.
Published: (2012-02-01)

Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer
by: K. N Srinivasan, et al.
Published: (2014-01-01)

Phase II study of the combination carboplatin <it>plus </it>celecoxib in heavily pre-treated recurrent ovarian cancer patients
by: Fuoco Gilda, et al.
Published: (2011-05-01)

A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
by: Panagiotis A. Konstantinopoulos, et al.
Published: (2021-09-01)

Limitations to the use of carboplatin-based therapy in advanced ovarian cancer
by: Christina Fotopoulou
Published: (2014-12-01)

Long Term Oral Etoposide As Second-Line Therapy In Recurrent Epithelial Carcinoma Of The Ovary
by: Azam Sadat Moosavi, et al.
Published: (2005-01-01)

Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2020-01-01)

Single-Cell RNA Sequencing of Hematopoietic Stem and Progenitor Cells Treated with Gemcitabine and Carboplatin
by: Niclas Björn, et al.
Published: (2020-05-01)

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX
by: Takatori E, et al.
Published: (2013-07-01)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
by: Yuri Nakao, et al.
Published: (2020-04-01)

Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
by: Weng CS, et al.
Published: (2019-11-01)

Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial
by: Hanan Shawky, et al.
Published: (2014-09-01)

Centralization of ovarian cancer surgery: Do patients benefit?
by: Ghaemmaghami F, et al.
Published: (2007-08-01)

Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-07-01)

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
by: Eric A Benson, et al.
Published: (2015-01-01)

Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer
by: Hamid Attarian, et al.
Published: (2009-09-01)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01)

Gemcitabine in Recurrent Meningioma
by: Satvik Khaddar, et al.
Published: (2020-10-01)

Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
by: Zhang Y, et al.
Published: (2018-12-01)

Low Grade Endometrial Stromal Sarcoma of Uterine: Review of 17 Cases
by: Nadereh Behtash, et al.
Published: (2011-09-01)

Low Grade Endometrial Stromal Sarcoma of Uterine: Review of 17 Cases
by: Nadereh Behtash, et al.
Published: (2011-09-01)

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
by: Qian Jiong, et al.
Published: (2007-06-01)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
by: Kamalika Samanta, et al.
Published: (2019-11-01)

Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
by: Yu Xun, et al.
Published: (2018-04-01)